Men's Health points people on GLP-1 drugs to its guide on training through weight loss so more of what comes off is fat, not muscle.
Recap by typeshit. Post by @menshealthmag on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
10:44
A personal account of a month on retatrutide, a drug still in trials and not approved for sale. It amounts to one person's anecdote, with no sourcing given.
An unsourced alert says compounded injectables, sermorelin included, face scrutiny over sterility. It names no regulator or official action.
Loading…